109 related articles for article (PubMed ID: 27297584)
1. In Silico Identification of Human miR 3654 and its Targets Revealed its Involvement in Prostate Cancer Progression.
Saravanan S; Islam VI; Thirugnanasambantham K; Sekar D
Microrna; 2016; 5(2):140-145. PubMed ID: 27297584
[TBL] [Abstract][Full Text] [Related]
2. Computational Identification of microRNA-17-3p in Breast Cancer Cells.
Shincy JS; Panagal M; Jereena J; Vengatagiri GY; Vittalrao KR; Sivakumar P; Gopinath V; Kumar KM; Sekar D
Microrna; 2017 Dec; 6(3):208-212. PubMed ID: 28875846
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
[TBL] [Abstract][Full Text] [Related]
4. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
[TBL] [Abstract][Full Text] [Related]
5. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression.
Fan X; Chen X; Deng W; Zhong G; Cai Q; Lin T
BMC Cancer; 2013 Feb; 13():61. PubMed ID: 23383988
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
8. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
[TBL] [Abstract][Full Text] [Related]
9. Expression profile analysis reveals putative prostate cancer-related microRNAs.
Song H; Liu Y; Pan J; Zhao ST
Genet Mol Res; 2013 Oct; 12(4):4934-43. PubMed ID: 24301753
[TBL] [Abstract][Full Text] [Related]
10. Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer.
Coradduzza D; Cruciani S; Arru C; Garroni G; Pashchenko A; Jedea M; Zappavigna S; Caraglia M; Amler E; Carru C; Maioli M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163550
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
[TBL] [Abstract][Full Text] [Related]
12. MiR-26a inhibits prostate cancer progression by repression of Wnt5a.
Zhao S; Ye X; Xiao L; Lian X; Feng Y; Li F; Li L
Tumour Biol; 2014 Oct; 35(10):9725-33. PubMed ID: 24972966
[TBL] [Abstract][Full Text] [Related]
13. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
14. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
[TBL] [Abstract][Full Text] [Related]
15. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.
Fu X; Zhang W; Su Y; Lu L; Wang D; Wang H
Prostate; 2016 May; 76(6):543-51. PubMed ID: 26771762
[TBL] [Abstract][Full Text] [Related]
17. MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches.
Aghaee-Bakhtiari SH; Arefian E; Naderi M; Noorbakhsh F; Nodouzi V; Asgari M; Fard-Esfahani P; Mahdian R; Soleimani M
Tumour Biol; 2015 Jun; 36(6):4203-12. PubMed ID: 25604141
[TBL] [Abstract][Full Text] [Related]
18. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.
Leite KR; Sousa-Canavez JM; Reis ST; Tomiyama AH; Camara-Lopes LH; Sañudo A; Antunes AA; Srougi M
Urol Oncol; 2011; 29(3):265-9. PubMed ID: 19372056
[TBL] [Abstract][Full Text] [Related]
19. miRNAs differentially expressed in prostate cancer cell lines after soy treatment.
Rabiau N; Trraf HK; Adjakly M; Bosviel R; Guy L; Fontana L; Bignon YJ; Bernard-Gallon DJ
In Vivo; 2011; 25(6):917-21. PubMed ID: 22021684
[TBL] [Abstract][Full Text] [Related]
20. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J
Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]